Vertex Pharmaceuticals Stock Price History
| VRTX Stock | USD 503.20 6.98 1.37% |
Below is the normalized historical share price chart for Vertex Pharmaceuticals extending back to July 24, 1991. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Vertex Pharmaceuticals stands at 503.20, as last reported on the 22nd of March, with the highest price reaching 510.08 and the lowest price hitting 501.07 during the day.
If you're considering investing in Vertex Stock, it is important to understand the factors that can impact its price. Vertex Pharmaceuticals appears to be very steady, given 3 months investment horizon. Vertex Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.25, which indicates the firm had a 0.25 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Vertex Pharmaceuticals, which you can use to evaluate the volatility of the company. Please review Vertex Pharmaceuticals' Risk Adjusted Performance of 0.0672, coefficient of variation of 1444.72, and Semi Deviation of 2.58 to confirm if our risk estimates are consistent with your expectations.
At this time, Vertex Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 23.7 B in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 156.8 M in 2025. . At this time, Vertex Pharmaceuticals' Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 1.77 in 2025, whereas Price To Sales Ratio is likely to drop 8.94 in 2025. Vertex Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 24th of July 1991 | 200 Day MA 469.7017 | 50 Day MA 466.7044 | Beta 0.415 |
Vertex |
Sharpe Ratio = 0.251
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | VRTX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.48 actual daily | 13 87% of assets are more volatile |
Expected Return
| 0.37 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.25 actual daily | 19 81% of assets perform better |
Based on monthly moving average Vertex Pharmaceuticals is performing at about 19% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vertex Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 7.8745 | Enterprise Value Ebitda 256.7351 | Price Sales 11.8882 | Shares Float 256 M | Wall Street Target Price 496.7759 |
Vertex Pharmaceuticals Stock Price History Chart
There are several ways to analyze Vertex Stock price data. The simplest method is using a basic Vertex candlestick price chart, which shows Vertex Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | March 17, 2025 | 513.76 |
| Lowest Price | December 30, 2024 | 399.35 |
Vertex Pharmaceuticals March 22, 2025 Stock Price Synopsis
Various analyses of Vertex Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Vertex Stock. It can be used to describe the percentage change in the price of Vertex Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Vertex Stock.| Vertex Pharmaceuticals Price Rate Of Daily Change | 0.99 | |
| Vertex Pharmaceuticals Price Action Indicator | (5.87) | |
| Vertex Pharmaceuticals Price Daily Balance Of Power | (0.77) |
Vertex Pharmaceuticals March 22, 2025 Stock Price Analysis
Vertex Stock Price History Data
The price series of Vertex Pharmaceuticals for the period between Sun, Dec 22, 2024 and Sat, Mar 22, 2025 has a statistical range of 117.12 with a coefficient of variation of 7.87. The daily prices for the period are distributed with arithmetic mean of 455.1. The median price for the last 90 days is 462.58. The company experienced 2:1 stock split on 24th of August 2000.| Open | High | Low | Close | Volume | ||
03/22/2025 | 505.43 | 510.08 | 501.07 | 503.20 | ||
| 03/21/2025 | 505.43 | 510.08 | 501.07 | 503.20 | 2,021,047 | |
| 03/20/2025 | 510.00 | 515.67 | 505.75 | 510.18 | 1,064,516 | |
| 03/19/2025 | 512.01 | 514.82 | 505.00 | 512.52 | 1,109,236 | |
| 03/18/2025 | 510.30 | 516.50 | 508.52 | 512.23 | 1,249,743 | |
| 03/17/2025 | 505.12 | 517.20 | 505.00 | 513.76 | 1,015,064 | |
| 03/14/2025 | 507.00 | 519.68 | 502.33 | 504.77 | 1,386,150 | |
| 03/13/2025 | 493.79 | 512.75 | 488.00 | 502.92 | 1,693,038 | |
| 03/12/2025 | 484.62 | 496.64 | 483.09 | 495.42 | 1,368,594 | |
| 03/11/2025 | 496.86 | 497.50 | 480.29 | 488.34 | 1,196,943 | |
| 03/10/2025 | 483.39 | 503.83 | 480.38 | 500.01 | 1,794,588 | |
| 03/07/2025 | 485.71 | 492.34 | 482.82 | 488.29 | 1,195,991 | |
| 03/06/2025 | 490.15 | 491.62 | 479.78 | 485.72 | 1,325,400 | |
| 03/05/2025 | 485.25 | 495.54 | 483.54 | 491.64 | 997,924 | |
| 03/04/2025 | 485.49 | 490.69 | 480.11 | 486.22 | 1,146,289 | |
| 03/03/2025 | 477.82 | 490.65 | 477.73 | 483.31 | 1,243,696 | |
| 02/28/2025 | 479.90 | 484.32 | 474.01 | 479.79 | 2,284,507 | |
| 02/27/2025 | 475.34 | 486.07 | 473.51 | 474.50 | 913,498 | |
| 02/26/2025 | 478.18 | 484.91 | 474.24 | 479.10 | 739,293 | |
| 02/25/2025 | 480.95 | 485.98 | 476.26 | 480.35 | 1,115,113 | |
| 02/24/2025 | 482.84 | 487.50 | 479.12 | 481.65 | 1,067,339 | |
| 02/21/2025 | 481.36 | 487.38 | 479.85 | 484.24 | 1,315,240 | |
| 02/20/2025 | 474.01 | 481.13 | 472.80 | 480.33 | 1,574,270 | |
| 02/19/2025 | 463.12 | 472.12 | 461.91 | 471.76 | 1,454,600 | |
| 02/18/2025 | 455.06 | 465.12 | 451.99 | 462.11 | 1,377,919 | |
| 02/14/2025 | 462.50 | 469.34 | 457.44 | 459.00 | 881,205 | |
| 02/13/2025 | 454.83 | 465.68 | 450.60 | 462.58 | 1,299,733 | |
| 02/12/2025 | 451.83 | 455.66 | 446.00 | 453.20 | 1,137,900 | |
| 02/11/2025 | 460.00 | 468.19 | 452.49 | 455.22 | 1,558,175 | |
| 02/10/2025 | 471.94 | 471.94 | 464.01 | 469.97 | 1,736,174 | |
| 02/07/2025 | 478.98 | 480.47 | 468.70 | 469.32 | 1,191,954 | |
| 02/06/2025 | 487.79 | 488.43 | 478.81 | 481.16 | 1,009,943 | |
| 02/05/2025 | 485.00 | 491.81 | 481.70 | 488.44 | 1,541,503 | |
| 02/04/2025 | 468.04 | 482.74 | 467.30 | 482.28 | 2,029,500 | |
| 02/03/2025 | 463.36 | 473.07 | 458.74 | 470.37 | 2,189,200 | |
| 01/31/2025 | 454.17 | 472.04 | 447.20 | 461.68 | 3,648,800 | |
| 01/30/2025 | 443.56 | 444.28 | 435.00 | 438.40 | 1,167,300 | |
| 01/29/2025 | 437.74 | 442.92 | 430.81 | 441.52 | 1,026,500 | |
| 01/28/2025 | 443.88 | 446.98 | 438.01 | 440.68 | 1,159,600 | |
| 01/27/2025 | 436.72 | 447.72 | 435.33 | 443.88 | 1,613,600 | |
| 01/24/2025 | 438.73 | 442.66 | 436.61 | 439.62 | 1,647,800 | |
| 01/23/2025 | 429.25 | 442.89 | 424.54 | 439.73 | 1,658,000 | |
| 01/22/2025 | 427.89 | 432.60 | 424.65 | 428.00 | 1,215,400 | |
| 01/21/2025 | 427.94 | 430.53 | 423.49 | 427.89 | 1,561,100 | |
| 01/17/2025 | 422.73 | 428.25 | 419.27 | 422.00 | 1,773,600 | |
| 01/16/2025 | 423.41 | 424.58 | 415.15 | 416.96 | 1,226,100 | |
| 01/15/2025 | 415.13 | 425.49 | 415.13 | 424.26 | 1,722,100 | |
| 01/14/2025 | 411.94 | 414.50 | 408.02 | 411.66 | 1,376,400 | |
| 01/13/2025 | 408.00 | 416.55 | 397.25 | 413.37 | 1,859,600 | |
| 01/10/2025 | 406.17 | 413.52 | 405.17 | 409.56 | 1,687,900 | |
| 01/08/2025 | 410.71 | 412.36 | 407.24 | 412.11 | 1,173,900 | |
| 01/07/2025 | 403.00 | 410.81 | 401.54 | 408.32 | 1,679,900 | |
| 01/06/2025 | 401.31 | 404.74 | 399.00 | 402.49 | 2,176,400 | |
| 01/03/2025 | 407.57 | 411.65 | 406.40 | 407.11 | 1,086,900 | |
| 01/02/2025 | 403.14 | 409.60 | 402.72 | 405.76 | 1,277,700 | |
| 12/31/2024 | 399.63 | 404.99 | 399.63 | 402.70 | 1,048,100 | |
| 12/30/2024 | 404.54 | 407.35 | 399.06 | 399.35 | 1,456,000 | |
| 12/27/2024 | 405.26 | 410.98 | 404.49 | 408.76 | 1,373,400 | |
| 12/26/2024 | 407.20 | 411.29 | 406.02 | 410.65 | 1,191,500 | |
| 12/24/2024 | 401.53 | 410.68 | 401.27 | 408.18 | 1,468,600 | |
| 12/23/2024 | 391.87 | 405.93 | 390.92 | 405.27 | 2,204,300 |
About Vertex Pharmaceuticals Stock history
Vertex Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vertex is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vertex Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vertex Pharmaceuticals stock prices may prove useful in developing a viable investing in Vertex Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 257.9 M | 156.8 M | |
| Net Income Applicable To Common Shares | 3.8 B | 4 B |
Vertex Pharmaceuticals Quarterly Net Working Capital |
|
Vertex Pharmaceuticals Stock Technical Analysis
Vertex Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
Vertex Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Vertex Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Vertex Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vertex to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0672 | |||
| Jensen Alpha | 0.1381 | |||
| Total Risk Alpha | 0.2978 | |||
| Sortino Ratio | 0.0723 | |||
| Treynor Ratio | 7.2 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Vertex Stock Analysis
When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.